MJARF (MJardin Group) EBIT: $-26.73 Mil (TTM As of Sep. 2021)


What is MJardin Group EBIT?

MJardin Group MJARF -99.00% EBIT is $-26.73 Mil as of Sep. 2021.

MJardin Group's earnings before interest and taxes (EBIT) for the three months ended in Sep. 2021 was $-12.90 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2021 was $-26.73 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. MJardin Group's annualized ROC % for the quarter that ended in Sep. 2021 was -21.36%. MJardin Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2021 was -189.65%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield.


MJardin Group  (OTCPK:MJARF) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

MJardin Group's annualized ROC % for the quarter that ended in Sep. 2021 is calculated as:

ROC % (Q: Sep. 2021 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2021 ) + Invested Capital (Q: Sep. 2021 ))/ count )
=-14.048 * ( 1 - 0% )/( (74.023 + 57.52)/ 2 )
=-14.048/65.7715
=-21.36 %

where

Note: The Operating Income data used here is four times the quarterly (Sep. 2021) data.

2. Joel Greenblatt's definition of Return on Capital:

MJardin Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2021 is calculated as:

ROC (Joel Greenblatt) %(Q: Sep. 2021 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2021  Q: Sep. 2021
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-51.604/( ( (34.51 + max(-9.161, 0)) + (19.911 + max(-6.396, 0)) )/ 2 )
=-51.604/( ( 34.51 + 19.911 )/ 2 )
=-51.604/27.2105
=-189.65 %

where Working Capital is:

Working Capital(Q: Jun. 2021 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.464 + 7.356 + 4.78) - (21.634 + 0.127 + 0)
=-9.161

Working Capital(Q: Sep. 2021 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.952 + 5.779 + 8.18) - (21.187 + 0.12 + -3.5527136788005E-15)
=-6.396

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Sep. 2021) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

MJardin Group's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Sep. 2021 )
=-26.726/0.000
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MJardin Group EBIT Related Terms


MJardin Group EBIT Historical Data

* Premium members only.

The historical data trend for MJardin Group's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MJardin Group EBIT Chart

MJardin Group Annual Data
Trend Aug11 Aug12 Aug13 Aug14 Aug15 Aug16 Aug17 Aug18 Dec19 Dec20
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.07 -0.07 -0.08 -189.62 -2.37

MJardin Group Quarterly Data
Nov16 Feb17 May17 Aug17 Nov17 Feb18 May18 Aug18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.69 -12.23 1.39 -2.98 -12.90

MJARF vs EAPH, FPSUF, GCAN: EBIT Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, MJardin Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MJardin Group EV-to-EBIT vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MJardin Group's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where MJardin Group's EV-to-EBIT falls into.



MJardin Group EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Sep. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-26.73 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $-26.73 Mil mean?
MJardin Group (MJARF) has a EBIT of $-26.73 Mil as of Sep. 2021. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on MJardin Group.
Is MJardin Group's EBIT too high?
MJardin Group's current EBIT is $-26.73 Mil.
How does MJardin Group's EBIT compare to EAPH and FPSUF?
MJardin Group's EBIT of $-26.73 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Drug Manufacturers company?
A good EBIT depends on the Drug Manufacturers industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on MJardin Group. MJardin Group's current EBIT is $-26.73 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MJardin Group stock overvalued right now?
MJardin Group (MJARF) has a current EBIT of $-26.73 Mil. The current EBIT is $-26.73 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For MJardin Group (MJARF), the current EBIT is $-26.73 Mil as of Sep. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MJardin Group Business Description

Address 1 Toronto Street, Suite 801, Toronto, ON, CAN, M5C 2V6
MJardin Group Inc is a Canada based cannabis cultivation and management company. It is engaged in the cultivation, processing, and distribution of medical cannabis. The company's operating segment includes Cultivation management in USA and Cultivation operations in Canada. It generates maximum revenue from the Cultivation management in USA segment. Cultivation management in USA segment engaged in the management services to owners of cultivation and dispensary facilities. The services provided are consulting, design, operational, and other management services.